VAERS Explorer
Back to explore

Report #2877033

Received Dec 9, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
75 yrs
State
FL
Recovered
Recovered
Vaccinated
Oct 2, 2023
Onset
Oct 1, 2023
Days to onset
—
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (PFIZER-BIONTECH))PFIZER\BIONTECH1—OT
FLU3INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE)SANOFI PASTEURUNK—OT

Symptoms (2)

AstheniaFatigue

Symptom narrative

full body weakness and fatigue; full body weakness and fatigue; This is a spontaneous report received from an Other HCP, Program ID. A 75-year-old male patient received BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 02Oct2023 as dose 1, single (Batch/Lot number: unknown) at the age of 75 years intramuscular for covid-19 immunisation; influenza vaccine inact split 3v (FLUZONE HIGH DOSE), on 02Oct2023 as dose number unknown, single intramuscular for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ASTHENIA (non-serious), FATIGUE (non-serious) all with onset Oct2023, outcome "recovered" (Oct2023) and all described as "full body weakness and fatigue". Additional information: For 2 days the patient experienced full body weakness and fatigue. Patient was unable to get out of bed. After the 2 days all symptoms completely resolved. The information on the batch/lot number for BNT162b2 omi xbb.1.5 will be requested and submitted if and when received.